NASDAQ: LIPO
Lipella Pharmaceuticals Inc Stock Ownership - Who owns Lipella Pharmaceuticals?

Insider buying vs selling

Have Lipella Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when LIPO insiders and whales buy or sell their stock.

LIPO Shareholders

What type of owners hold Lipella Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Jonathan H. Kaufman20.12%898,849$2.37MInsider
Michael B. Chancellor19.65%877,637$2.32MInsider
Tower Research Capital LLC Trc0.06%2,708$7.15kInstitution
Mai Capital Management0.00%125$330.00Institution
Bank Of America Corp0.00%7$18.48Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

LIPO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LIPO0.06%39.77%
ATHA44.99%31.83%Net Selling
BOLT47.85%52.15%Net Buying
BCTX0.57%99.43%
ALLR0.61%13.17%Net Buying

Lipella Pharmaceuticals Stock Ownership FAQ

Who owns Lipella Pharmaceuticals?

Lipella Pharmaceuticals (NASDAQ: LIPO) is owned by 0.06% institutional shareholders, 39.77% Lipella Pharmaceuticals insiders, and 60.17% retail investors. Jonathan H. Kaufman is the largest individual Lipella Pharmaceuticals shareholder, owning 898,849.00 shares representing 20.12% of the company. Jonathan H. Kaufman's Lipella Pharmaceuticals shares are currently valued at $2.37M.

If you're new to stock investing, here's how to buy Lipella Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.